Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): A Multicenter, Randomized, Placebo-Controlled, Phase 2 Trial
PDF) Treatment of intracerebral haemorrhage with tranexamic acid - A review of current evidence and ongoing trials
PDF) Tranexamic Acid for Spontaneous Intracerebral Hemorrhage: A Randomized Controlled Pilot Trial (ISRCTN50867461)
PDF] Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH- 2): an international randomised, placebo-controlled, phase 3 superiority trial
MORE
Bernhard SIEPEN, Medical Doctor, Inselspital, Universitätsspital Bern, Bern, Department of Neurology
Haemostatic therapies for stroke due to acute, spontaneous intracerebral haemorrhage - Eilertsen, H - 2023
Neuroprotective strategies following intraparenchymal hemorrhage
Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage - Sembill - 2020 - Annals of Clinical and Translational Neurology - Wiley Online Library
PDF) Hematoma expansion in intracerebral hemorrhage – the right target?
Brian Gilbert, PharmD, MBA, FCCM, FNCS on X: *from the rooftops* TXA is a narrow spectrum hemostatic agent. DOAC-associated ICH needs thrombin generation. I've never read anything that DOACs increase fibrinolysis so not sure why we put TXA in
